Delivery Order SPE2DB22D2108-SPE2DB26FU2RE
- Not listed
- The Defense Logistics Agency awarded a $24,219.96 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Jardiance 25 mg tablets (90-count units). The contract utilizes firm fixed pricing with a non-competitive set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $32,975.40 on October 29, 2025, for the supply of Jardiance 25 mg tablets in quantities of 90 units. This firm fixed-price, non-set-aside contract is scheduled for completion by October 30, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on August 19, 2025, for supply of Jardiance 10 mg tablets in quantities of 90 units, with a ceiling value of $62,283.78 and firm fixed pricing. This non-set-aside, competitively awarded contract is scheduled for completion by August 20, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under the company's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,297.06 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on June 27, 2025, with completion scheduled for June 30, 2025. This firm fixed price, competitively awarded delivery order represents a pharmaceutical supply requirement without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the place of...
- The Defense Logistics Agency awarded a $25,812.07 delivery order to AmerisourceBergen Drug Corp for 90-count packages of Jardiance 25 mg tablets under a firm fixed price contract type. The award was made on September 15, 2025, with an ultimate completion date of September 16, 2025, and represents a non-competitive set-aside procurement. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office...
- The Defense Logistics Agency awarded a $26,337.42 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 21, 2025, and performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $55,821.37 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply needs, consistent with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) valued at $6,733.04 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by October 24, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order against AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,606.96 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on October 24, 2025, with an ultimate completion date of October 27, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB26FU2REDelivery Order
The Defense Logistics Agency awarded a $29,696.06 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 31, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a task under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to military healthcare programs worldwide. Jardiance, a diabetes management medication, aligns with AmerisourceBergen's demonstrated portfolio of specialty pharmaceuticals and therapeutic medications supplied across federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 10/30/25 |